AACOCF3 is a potent and selective slow-binding inhibitor of 85-kDa cytosolic phospholipase A2 (cPLA2); it inhibits arachidonic acid and 12-hydroxyeicosatetraenoic acid production in calcium ionophore-stimulated platelets; suppresses glucose-induced insulin secretion in isolated rat islets; and shows potential for research in cardiovascular and cerebrovascular diseases.